Evidence concerning ion-channel abnormalities in the pathophysiology of common psychiatric disorders is still limited. Given the significance of ion channels in neuronal activity, neurotransmission and neuronal plasticity we hypothesized that the expression patterns of genes encoding different ion channels may be altered in schizophrenia, bipolar and unipolar disorders. Frozen samples of striatum including the nucleus accumbens (Str-NAc) and the lateral cerebellar hemisphere of 60 brains from depressed (MDD), bipolar (BD), schizophrenic and normal subjects, obtained from the Stanley Foundation Brain Collection, were assayed. mRNA of 72 different ion-channel subunits were determined by qRT-PCR and alteration in four genes were verified by immunoblotting. In the Str-NAc the prominent change was observed in the MDD group, in which there was a significant up-regulation in genes encoding voltage-gated potassiumchannel subunits. However, in the lateral cerebellar hemisphere (cerebellum), the main change was observed in schizophrenia specimens, as multiple genes encoding various ion-channel subunits were significantly down-regulated. The impaired expression of genes encoding ion channels demonstrates a disease-related neuroanatomical pattern. The alterations observed in Str-NAc of MDD may imply electrical hypo-activity of this region that could be of relevance to MDD symptoms and treatment. The robust unidirectional alteration of both excitatory and inhibitory ion channels in the cerebellum may suggests cerebellar general hypo-transcriptional activity in schizophrenia.
Introduction
Ion channels are an essential substrate for neuronal, cardiac and skeletal muscle excitability. Channelopathies have been well recognized in the aetiology of hereditary cardiac arrhythmias and in rare inherited types of common neurological diseases such as epilepsy, ataxia and migraine (Catterall et al. 2008 ; Roberts & Gollob, 2010) . Such knowledge is still limited in psychiatry, yet indications concerning ion-channel alterations in the pathophysiology of psychiatric disorders are emerging. For example, neurobiological theories involving kindling and rekindling-like phenomena have been suggested to explain the pathogenesis of bipolar disorder (BD). Kindling is a consequence of neuronal hyperexcitability followed by repetitive circulation of impulses (rekindling), which possibly maintain the affective event (Mazza et al. 2007 ). Ion-channel abnormalities are attractive candidates involved in the suggested aberrations of depolarization and/or repolarization processes in BD, and may contribute to the episodic course of illness in this disorder. Large genome-wide association studies point to the involvement of ion channels in the pathogenesis of the BD (Moskvina et al. 2009 ; O'Donovan et al. 2009) . A single nucleotide polymorphism in the CACNA1C gene (rs1006737, G-A), which encodes for a voltage-dependent Ca 2+ L-type a-channel subunit, was repetitively reported as a susceptible loci for bipolar disorder (Ferreira et al. 2008) . Recently, it was reported that this gene also confers risk of recurrent major depression (MDD) and of schizophrenia (Green et al. 2010) . Human association studies show that KCNK2 is another susceptible gene for MDD, and is involved in antidepressant treatment response (Liou et al. 2009 ). This gene encodes one of the members of the potassium channel family that leaks potassium out of the cell to control resting membrane potential. Several studies suggest that modulation of ion-channel activity can reduce depression-like behavior in animal models (Lodge & Li, 2008) . For example, genetical disruption of ASIC1A (amiloride-sensitive cation channel) in mice as well as its pharmacological inhibition, produced antidepressant-like effects in the forced swim test (Coryell et al. 2009 ). In schizophrenia, a meta-analysis of five independent clinical association datasets identified KCNH2 [human ether-a-go-go family potassium channel (hERG1)] as a potential schizophrenia susceptible gene (Huffaker et al. 2009) .
Additional indication for the significance of ionchannel alterations in psychiatric disorders appears from the mode of action of mood-stabilizing drugs that directly interfere with ion-channel activity to achieve their therapeutic effect. Lithium as well as the anticonvulsants carbamazepine, valproate, lamotrigine and topiramate, seem to share a powerful inhibition of voltage-activated sodium channels, leading to decreased neuronal excitability (Dichter, 1998) . In addition, positive modulatory effects on early potassium outward currents that can lead to the repolarization of depolarized neurons have been described for carbamazepine, valproate and lamotrigine. Lithium, carbamazepine and valproate act also on the influx of calcium into the cell or its release from intracellular stores (Amann & Grunze, 2005) .
Interference with ion-channel activity has also been reported for antipsychotic and antidepressants drugs. Clinical and experimental evidence suggests that members of different antipsychotic drug classes including phenothiazine, butyrophenone and other structurally heterogeneous antipsychotic drugs as well as some tricyclic antidepressants have the ability to block potassium channels such as those encoded by ether-a-go-go-related gene (Calderone et al. 2005 ; Hong et al. 2010) . The potency of tricyclic antidepressants as sodium-channel inhibitors was repetitively shown in vitro (Nicholson et al. 2002 ; Pancrazio et al. 1998) , while in vivo the ability to inhibit sodium channels underlies their efficiency in the treatment of neuropathic pain (Namaka et al. 2004) . Substantial blockage of K + currents through a variety of potassium channels in mammalian neurons can occur at therapeutic levels of the selective serotonin reuptake inhibitor (SSRI), fluoxetine and could lead to increased neuronal excitability (Kennard et al. 2005 ; Ohno et al. 2007 ; Yeung et al. 1999) . A resent study demonstrated that potassium channels are also involved in the antidepressant-like effect of the selective noradrenaline reuptake inhibitor (SNRI), venlafaxine, in mice (Bortolatto et al. 2010 ).
Animal models with genetic engineering of ionchannel subunits were mostly used for the demonstration of different neurological phenotypes such as seizures, pain and locomotion (Catterall et al. 2008) . However, few studies have shown deficits in associative learning and memory including late-phase LTP as well as altered emotional behaviour associated with stress in mice with genetic alteration in potassium, sodium and calcium channel subunits, respectively (Moosmang et al. 2005) .
Given the significance of ion channels in neuronal activity, neurotransmission, neuronal plasticity and the formation of neuronal circuitry, which regulates major processes relevant to psychiatric disorders, led us to study the expression of genes encoding subunits of different ion channels in schizophrenia, BD, MDD and healthy subjects in the striatal-nucleus accumbens (Str-NAc) and lateral cerebellar hemisphere post-mortem specimens, both anatomical substrates implicated in these disorders (Abler et al. 2008 ; Andreasen & Pierson, 2008 ; Ben-Shachar & Karry, 2008 ; Peng et al. 2010 ; Pizzagalli et al. 2009 ; Rimol et al. 2010) .
Methods

Post-mortem tissues
Frozen samples from the striatum including the nucleus accumbens (Str-NAc), and the lateral cerebellar hemisphere, were provided by the Stanley Foundation Neuropathology Consortium (USA). Samples were obtained from individuals diagnosed (DSM-IV criteria) with schizophrenia, BD or MDD and normal controls (n=15 subjects in each group). Detailed clinical information, diagnostic procedures and demographic information on these subjects and protection of human rights was as previously reported (Torrey et al. 2000) . Main demographic details and medication undertaken by each patient are summarized in Tables 1 and 2 , respectively. The four groups were matched by age, sex, race, post-mortem interval (PMI), pH, laterality, and mRNA quality. The investigators were blind to patients' diagnosis throughout the experimental procedure.
Immunoblotting
Protein isolated from frozen specimens was analysed by immunoblotting three times for each individual (Ben-Shachar & Karry, 2007 ; Dror et al. 2002) . Protein samples were separated on SDS-PAGE. Primary recombinant anti-human antibodies (1 : 200) used were : anti-SK3 (KCNN3), anti-K v 9.3 (KCNS3), anti-K v 1.1 (KCNA1) and anti-CLC7 (CLCN7). Secondary antibodies used were : anti-goat/rabbit-IgG 1 : 3000 for SK3 and K v 9.3 and 1 : 2000 for K v 1.1 and CLC7 (Santa Cruz Biotechnology, USA). Membranes were blocked with BLOT-QuickBlocker (Chemicon, Millipore Co., USA) and the primary and secondary antibodies were prepared using SignalBoost Immunoreaction Enhancer kit (Calbiochem, Merck KGaA, Germany). b-actin was used for normalizing variations in protein aliquots, as its levels were not affected by disease. In addition, a single batch of human brain protein in three different concentrations was used as a positive control and for between-sample sets normalization.
q-PCR array
RNA was extracted from tissue using RNA-STAT-60 kit (Tel-Test, USA) and treated by DNase as described previously (Ben-Shachar & Karry, 2007 ; Dror et al. 2002) . The high quality of RNA was verified by its integrity depicted in the form of three bands corresponding to 28S, 18S and 5S RNA assessed by electrophoresis, and spectophotometrically by its samples of each of the four groups, and for 13, 14, 13 and 12 out of 15 Str-NAc samples of schizophrenia, BD, MDD and control groups, respectively. A list of the genes encoding for different subunits of the ion channels is given in Supplementary Table S1 (available online).
Data analysis
Data analysis was performed using the DDC t method. All C t values >35 were considered negative. C t values of the genomic DNA control >35 indicated a too low genomic DNA contamination to affect gene expression profiling results. Impurities in RNA preparations were analysed by subtracting the average C t of three positive PCR controls from that of three RNA transcription controls, assuming no interference with the reverse transcription if values obtained were <2.5. The effect of impurities of the RNA preparation on PCR amplification was considered negligible if the average C t values of the three positive PCR controls was 20¡2.
DC t for each gene for each brain sample was calculated by subtracting the average C t of the two most stable housekeeping genes GAPDH and RPL13A, which did not differ between the diagnostic groups. DDC t for each gene was calculated by subtracting the average DC t of the control group from that of each of the patient groups.
Normal distribution of data (DC t and protein levels) was analysed by Kolmogorov-Smirnov test. For further analysis parametric tests were used, as most data (92 %) presented normal distribution. For data not distributed normally, non-parametric and parametric tests showed similar differences between groups. Data for each brain area were analysed by Student's t test comparing each patient group with the control group, as well as by one-way ANOVA followed by Scheffé 's post-hoc test. No correction for multiple testing was necessary, regarding p<0.05 only 3-4 genes out of the 72 analysed showed significant changes by chance. Our results show many more genes that were altered of which the majority showed much lower p values. Table 3 presents the genes encoding for ion channels that were significantly changed between the control group and each of the three patients groups BD, schizophrenia and MDD in the Str-NAc specimens using Student's t test analysis. In BD and schizophrenia specimens, four and five genes encoding subunits of three and four potassium ion channels, respectively, were significantly different from the controls. In MDD 15 genes encoding different ion channels, including different types of voltage-gated potassium, sodium and calcium channels were all, except the potassium subunit, KCNS3, up-regulated compared with controls. One-way ANOVA followed by Scheffé 's post-hoc test further supported that in the Str-NAc region the MDD group was significantly different from the control group in 21 % of the genes and from the other two patient groups for most (80 %) of these genes. KCNN3 was up-regulated and KCNS3 was down-regulated in all patient groups compared to the control group. The KCNN3 functional transcript is SK3, yet it is also alternatively spliced into SK3-1B and SK3-1C transcripts, encoding SK-family-wide dominant-negative silencers. The primer set used in this study for this gene recognizes only the functional SK3 transcript. The main difference between the MDD group and the other two patient groups was the larger variety of ion channels that were changed and the higher percentage of potassium channel subunits that were up-regulated in this group. In the lateral cerebellar hemisphere we observed a completely different pattern of change in gene expression (Table 3 ). In this brain region the schizophrenic group demonstrated the most robust change. A significant down-regulation compared to the control group was observed by Student's t test in 47 % of the genes encoding subunits of different types of ion channels including the chloride channels, voltagegated potassium, sodium and calcium channels as well as the amiloride-sensitive cation channel and ATPases, transporting Na
Results
Gene array results
way ANOVA followed by Scheffé 's post-hoc test further supported that in the cerebellar specimens the schizophrenia group was significantly different from the control group in 47 % of the genes encoding ion channels and from the other two patient groups for most (85 %) of these genes. In the BD group there was a significant up-regulation of three genes encoding subunits of voltage-gated potassium channel, KQTlike and shaker-related subfamilies, as well as two genes encoding the a-and b-subunits of voltage-gated type 1 sodium channel. In the MDD group none of the ion channels encoding genes were altered.
Demographic parameters, covariance analysis
To control for potential confounds, age, gender, PMI, brain pH, side of brain, duration of disease, age of onset, severity of alcohol and drug abuse and psychotropic medication were added as covariates, and assessed by ANCOVA for all the genes that were altered in any of the diseases in each brain region. Severity of alcohol and drug abuse was scored from 0 (no use) to 6 (heavy use). The disease-related significant differences observed in the striatum in the expression of all, but one gene CACNB3, were not altered by any of the parameters used as a covariate, including pH, alcohol and drug abuse and lifetime antipsychotic dose. For CACNB3 all the covariates obliterated the disease-related significance but none showed significant correlation with CACNB3. In the cerebellum, the significance of the disease-related alterations was not affected by any of the added covariates in 74 % of significantly altered genes in the entire cohort. Table 4 lists the 11 genes in which group differences were abolished by the addition of various covariates and presents those which showed a significant correlation with these genes. Most of the covariates including PMI, pH and medication did not show a significant correlation with any of these genes in all patient groups.
Effect of antipsychotic medication
Given the reported effects of antipsychotic drugs on ion channels (Calderone et al. 2005 ; Duncan et al. 2009) we redefined our group variable to define two subgroups ; antipsychotic-medicated schizophrenic or BD patients (11 or 9 schizophrenic, 6 or 5 BD patients for the Str-NAc and the cerebellum, respectively) and antipsychotic-unmedicated patients (3 schizophrenic, 8 or 7 BD patients). Three schizophrenic patients and three BD patients were medication free and the other five bipolar patients received other psychotrophic drugs. No significant difference was observed between the two subgroups in all genes in both the Str-NAc and the cerebellum, except for two geneS (5 % of the significantly altered genes), KCNA4 (p=0.022) and KCNB2 (p=0.011), which showed a significant difference between both groups in the cerebellum.
Effect of antidepressant medication
Given the reported effects of antidepressant drugs on ion channels (Bortolatto et al. 2010 ; Hong et al. 2010 ; Kennard et al. 2005 ; Nicholson et al. 2002 ; Ohno et al. 2007 ; Pancrazio et al. 1998 ; Yeung et al. 1999) , their effect in depressed subjects was assessed in the Str-NAc specimens, as no gene was altered in the MDD cerebellar specimens. We divided the MDD group into two subgroups : patients medicated with antidepressant drugs (n=8) and unmedicated (n=6) patients, two of them treated with other psychotropic drugs. No significant difference between groups was observed in the expression of any of the genes that showed significant differences due to the disease.
Effect of mood stabilizers
It is commonly accepted that mood-stabilizing drugs directly interfere with ion-channel activity to achieve their therapeutic effect (Dichter, 1998) . Therefore, we divided the bipolar group into two subgroups : patients medicated with mood stabilizers (n=9 or 7 for the Str-NAc and the cerebellum, respectively) and unmedicated (n=5 in both areas) patients, two of them treated with other psychotropic drugs. No significant difference was observed between the two subgroups for all genes in both brain areas except for ATP2A1 (p=0.038) in the cerebellum. To assess the effects of lithoum or valproate on these genes, we divided the BP group into two subgroups : patients medicated with lithium or valproate (n=4 for each treatment) and unmedicated with these drugs (n=8). No significant difference was observed between the two subgroups divided for either drug for all genes in both brain areas. We then redefined our group variable to include two subgroups : subjects receiving mood stabilizers (n=16 ; 10 bipolar, 3 depressed, 3 schizophrenic) and subjects not receiving mood stabilizers (n=40 or 32 for the Str-NAc and the cerebellum, respectively), there was no significant difference between groups in all genes in both brain areas except for KCNQ3 (p=0.012) and SCN1B (p=0.004) in the cerebellum.
Immunoblotting results
To confirm our finding of altered expression of genes encoding for ion channels we selected four genes for verification by immunoblotting. Protein levels of CLC7 (CLCN7), K v 1.1 (KCNA1), SK3 (KCNN3) and K v 9.3 (KCNS3) were measured in the Str-NAc, a region for which we had 14-15 protein samples from each group. We used anti-SK3 antibody specific for the unique N-terminus of SK3, which is not shared by SK3-1B and SK3-1C. (Fig. 1) .
Discussion
The main finding of the present study is abnormal expression of genes encoding ion channels in the Str-NAc and the lateral cerebellar hemisphere of patients with schizophrenia, MDD and BD, yet in a disease-related neuroanatomical pattern. Thus, a higher number of genes encoding for a larger variety of ion channels showed a significantly changed expression in the Str-NAc of the MDD group, while in schizophrenia the main change was observed in the cerebellar specimens. Only several genes were altered in the Str-NAc of schizophrenics and none was altered in the cerebellum of the MDD group. In the BD group only minor changes were observed in both areas. Interestingly, an analysis of the expression of genes encoding voltage-gated ion channels in the prefrontal cortex (BA 46), based on the Stanley Medical Research Institute Genomic Database pinpoints the prefrontal cortex as a major anatomical substrate of ion-channel gene abnormalities in BD (Higgs et al. 2006) . These alterations in ion-channel subunit expression are probably related to epigenetic mechanisms that program tissue-specific patterns of gene expression (McGowan et al. 2008) , since genetic variations in ion-channel subunits are expected to cause more widespread phenotypic changes involving neurological and cardiac dysfunction. We studied the Str-NAc, as compelling evidence links activation of the Str-NAc with response to emotional stimuli and reward functions which are commonly disturbed in all three disorders (Abler et al. 2008 ; Crespo-Facorro et al. 2001 ; Nestler & Carlezon, 2006 ; Pizzagalli, 2010) . In the Str-NAc of the MDD group the prominent change was a significant up-regulation of genes encoding voltage-gated potassium-channel subunits. If such a change in gene expression is associated with a parallel alteration in the activity of the potassium ion channels, it can lead to a neuronal tendency for hyper-polarization and decreased excitability in this brain area. The downregulation in the expression of the voltage-gated sodium channel a-subunit (SCN3A) and the up-regulation of two chloride channels (CLCN5 and CLCN7) further supports electrical hypoactivity in this region. The up-regulated expression of voltagedependent calcium-channel b-subunits (CACNB1, CACNB2) may indicate an opposite effect on neuronal activity, since b-subunits act to increase peak currents. However, this is a regulatory subunit, which can affect both the activation and inactivation kinetics of Ca 2+ channel and therefore may have a mild effect on neuronal activity. An alternative explanation for the up-regulation of genes encoding potassium and chloride channels and the down-regulation of the gene encoding SCN3A is that the change in gene expression is inversely correlated with the activity of ion channel as a compensatory mechanism for increased neuronal activation. Yet, an increased electrical activity in Str-NAc, a major area involved in reward and motivation, seems to contradict the suppressed behaviours observed in MDD. Indeed, emerging data point towards a link between the anhedonic symptoms in MDD and striatal hypo-responsivity and reduced caudate or NAc volumes (Baumann et al. 1999 ; Elliott et al. 1998 ; Epstein et al. 2006 ; Keedwell et al. 2005 ; Pizzagalli et al. 2009 ; Smoski et al. 2009 ; Steele et al. 2007) . Notably, accumulating evidence indicates that deep-brain stimulation of the ventral caudate and the ventral striatum is effective in individuals with MDD who failed to respond to conventional antidepressant treatments (Aouizerate et al. 2004 ; Bewernick et al. 2010) . The latter, further supports a role for potassium ion channels ' enhanced activity, in the Str-NAc in the pathophysiology of MDD. Among the seven up-regulated potassium-channel subunits in the Str-NAc, the maximum fold of change in MDD was demonstrated in two subunits of the K ir 2.3 potassium channel (KCNJ4 and KCNJ1). Interestingly, in-vitro over-expression of this potassium channel was sufficient to inhibit striatal neurons (Falk et al. 2008) . It was demonstrated that all subunits of the Kir2 family can be detected on somata and dendrites of most striatal neurons and play a key role in the regulation of dopaminergic and cholinergic neurotransmission within the striatum (Pruss et al. 2003 ). An additional channel, which plays a role in dopaminergic and serotonergic transmission, is SK3 (KCNN3). It has been reported that SK3 channeldeficient mice have enhanced dopamine and serotonin release and altered emotional behaviours (Jacobsen et al. 2008) . In addition, specific pharmacological blockade of SK channels led to bursting action potentials and increased dopamine release, suggesting the SK3 channel as an intrinsic pacemaker in dopaminergic neurons (Tomita et al. 2003 ; Wolfart et al. 2001) . SK3 is expressed abundantly in the regions implicated in psychiatric disorders including the hippocampus, the limbic system and midbrain regions. In schizophrenia, for example, it was shown by multiple studies that over-representation of longer alleles of CAG repeats in KCNN3 is associated with schizophrenia (Dror et al. 1999 ; Tomita et al. 2003) . However, a meta-analysis of association studies in schizophrenia show no significant relationship between risk for schizophrenia and bipolar disorder and CAG-repeat length (Glatt et al. 2003) . A more recent study shows that longer CAG repeats, which reduce SK3 channel activity, do not influence susceptibility to schizophrenia but is rather specifically associated with better performance in higher cognitive discrimination, selection and execution tasks in schizophrenia (Grube et al. 2011) . In our study KCNN3 expression was increased in Str-NAc in all disease groups. Although we did not measure the relative amounts of the functional SK3 transcript vs. the dominant-negative SK3-1B or SK3-1C transcripts, we show an increase in the full-length protein levels using the antibody against the unique N-terminus present in SK3 but not in SK3-1B or SK3-1C. Thus, it is conceivable to suggest an increase in SK3 activity, which is in line with the complex dopamine and serotonin transmission abnormalities and with poorer cognitive discrimination, selection and execution tasks implicated in all three mental disorders. Finally, apart from being involved in the generation and propagation of neuronal action potentials, the ion channels can modulate and integrate synaptic signals affecting synaptic plasticity. In this context the significant down-regulation of ACCN1 (ASIC2) in Str-NAc in the MDD group is in line with recent findings demonstrating the ASIC2 channel as a target of BDNF signalling, an important factor in the impaired neuronal plasticity in MDD (McIlwrath et al. 2005) .
The role of the cerebellum has traditionally been limited to coordination of voluntary movement, gait, posture, speech and motor function. However, evidence from studies of patients with overt cerebellar diseases as well as from normal subjects, suggests a possible role for the cerebellum in cognition, mood and behaviour (Rapoport et al. 2000 ; Schmahmann, 2004) . In the present study we observed an extensive and highly significant down-regulation in genes encoding subunits of different types of ion channels in the lateral cerebellar hemisphere of the schizophrenic group compared to controls. Such a robust unidirectional alteration of both excitatory and inhibitory ion channels makes it difficult to hypothesize the net effect on cerebellar neuronal firing, but may suggest a general hypo-transcriptional activity in this brain region in schizophrenia. The concept that there is a cerebellar component in the pathophysiology of schizophrenia is gaining momentum from recent morphometric, metabolic, and functional imaging studies (Andreasen & Pierson, 2008) . Most of these studies demonstrate smaller cerebellar volumes and indicate inverse relationships between the cerebellar volume and the severity of negative symptoms (Ichimiya et al. 2001 ; Nopoulos et al. 1999 ; Wassink et al. 1999) . Interestingly, a PET study of schizophrenic patients performing a word recalling cognitive test, revealed decreased cerebellar activation, along with decreased activity in the frontal (hypofrontality) and the temporal lobes as well as the thalamus compared to control subjects (Crespo-Facorro et al. 1999) . Aberrant cerebellar functioning was also reported in early-onset psychosis and was suggested as a crucial factor contributing to the impairment in the cortical-thalamiccerebellar-thalamic circuits observed in schizophrenia. Genetic studies suggest the L-type voltage-gated calcium channel (CACNA1C) as a risk gene in BD and schizophrenia (O'Donovan et al. 2009 ). In line with the latter, a significant down-regulation of CACNA1C was observed in the cerebellar area of schizophrenic samples, further supporting the relevance of this brain area to schizophrenia. The involvement of the cerebellum was also demonstrated in BD by functional neuroimaging studies (Ketter et al. 2001 ; Malhi et al. 2007 ; Strakowski et al. 2005 ). Yet in our study, unlike schizophrenia, only five subunits of two potassium and one sodium channels were altered in BD patients in this brain area and were all up-regulated. Although it is tempting to suggest that the opposite direction of change in the expression of ion-channel genes in schizophrenia and BD cerebellar specimens is related to the symptom differences between both disorders, at this stage of research with such small numbers of altered subunits, it would be too far-fetched.
Interference with ion-channel activity is a well accepted mode of action of mood stabilizers and has also been reported for antipsychotic and antidepressants drugs as well (Calderone et al. 2005 ; Dichter 1998 ; Ohno et al. 2007 ; Pancrazio et al. 1998) . In addition, it has been shown in animal models that chronic psychotropic drugs as well as electroconvulsive treatment (ECT) can modulate the expression of ion-channel subunits (Duncan et al. 2008 ; Hjaeresen et al. 2008) . Despite this evidence, in our study mood stabilizers, including lithium and valproate, antidepressants as well as antipsychotic drugs added as covariates had no effect on disease-related changes for all genes except for mood-stabilizer effects on KCNQ3 and SCN1B and antipsychotic drug effects on KCNA4 and KCNB2 in the cerebellum. Although these results should be viewed with caution due to the small sample size, the lack of effect of psychotropic drugs on ion channels may suggest that this pathology was not adequately addressed by conventional psychotropic treatments in our patient groups. PMI, age, age onset, disease duration, gender, side of brain, pH, or drug and alcohol abuse had no effect on disease differences in the Str-NAc. In the cerebellum 71 % of altered genes were not affected by these confounders. Almost none of the confounders show correlation with the alterations of the affected genes, suggesting that the robust change in ion-channel subunits is disease-related.
To confirm the changes in gene expression we measured protein levels of four different subunits of potassium and chloride ion channels in Str-NAc, an area for which we had protein samples. Gene selected for protein analysis showed various pattern of alterations in the different cohorts and were not affected by any of covariates in both brain areas. Thus, the expression of KCNN3 (SK3) and KCNS3 (K v 9.3) was up-and down-regulated, respectively, in all patient groups. CLCN7 (CLC7) was up-regulated in the MDD and BD groups, while KCNA1 (K v 1.1) was downregulated in BD. Alterations of their protein levels grossly matched the changes in gene expression, strengthening the validity of the gene array findings.
This study has certain limitations including the small sample size and the use of post-mortem specimens. In addition, we have measured mainly gene expression of ion-channel subunits, which does not always reflect channel activity. Finally, the shortage in RNA and protein samples per person prevented us from elaborating on specific genes, which were altered and are implicated in BP, schizophrenia or MDD. Nevertheless, one cannot disregard the most challenging finding of this study, the altered expression of ion-channel genes in the Str-NAc of MDD patients, which may imply electrical hypo-activity of neurons in this region. There is compelling evidence that this brain region and its dopaminergic input from the ventral tegmental area (VTA) is heavily involved in reward and motivation neurocircuitry (Carlezon & Thomas, 2009) . Given the prominence of anhedonia, reduced motivation and anergy in most individuals with depression, we propose that Str-NAc ion-channel alterations can substantially contribute to the pathophysiology and symptomatology of depression and may even be involved in its aetiology. Furthermore, it may enlighten the mechanisms underlying the clinical benefit of ECT and of deep-brain stimulation in this brain area, in MDD. Finally, given the effectiveness of electrical and pharmacological cardio-version, both well accepted tools to terminate various cardiac arrhythmias, the results of the present study may open the gate to the development of drugs interfering with ion-channel activity in the Str-NAc to counteract anhedonia and anergy that are often resistant to standard treatments in MDD.
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